LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis

Abstract Background This study aimed to explore the role and underlying molecular mechanisms of long non-coding RNA (lncRNA) LINC00342 in gastric cancer (GC). Methods The expression of LINC00342 in GC tissues was evaluated by Quantitative reverse transcription polymerase chain reaction (qRT-PCR). Si...

Full description

Bibliographic Details
Main Authors: Run Liu, Xianwu Yang
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-08829-x
_version_ 1819009231339126784
author Run Liu
Xianwu Yang
author_facet Run Liu
Xianwu Yang
author_sort Run Liu
collection DOAJ
description Abstract Background This study aimed to explore the role and underlying molecular mechanisms of long non-coding RNA (lncRNA) LINC00342 in gastric cancer (GC). Methods The expression of LINC00342 in GC tissues was evaluated by Quantitative reverse transcription polymerase chain reaction (qRT-PCR). Silencing of LINC00342 was conducted to investigate the effect of LINC00342 in vitro and in vivo. The underlying molecular mechanisms of LINC00342 were determined by dual luciferase reporter assay, Western blotting analysis and rescue experiments. Biological functions of LINC00342 were evaluated by cell counting kit-8 (CCK-8) assay, colony formation assay, wound healing assay and Transwell assays. In addition, a tumor model was used to verify the effect of LINC00342 in tumorigenesis in vivo. Results LINC00342 was significantly upregulated in GC tissues and cell lines. Silencing of LINC00342 efficiently inhibited proliferation, migration and invasion of AGS cells in vitro, and also suppressed the tumorigenesis of GC in vivo. Functional experiments showed that LINC00342 regulated the expression of canopy fibroblast growth factor signaling regulator 2 (CNPY2) by competitively sponging miR-545-5p. Rescue experiments showed that inhibition of miR-545-5p and overexpression of CNPY2 significantly reversed cell phenotypes caused by silencing of LINC00342. Conclusion LINC00342 plays a potential oncogenic role in GC by targeting the miR545-5p/CNPY2 axis, and might act as a novel therapeutic target for GC.
first_indexed 2024-12-21T00:53:05Z
format Article
id doaj.art-6f07ba7f396a4ef89e27a5ec52b1f2aa
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-21T00:53:05Z
publishDate 2021-10-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-6f07ba7f396a4ef89e27a5ec52b1f2aa2022-12-21T19:21:22ZengBMCBMC Cancer1471-24072021-10-0121111210.1186/s12885-021-08829-xLncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axisRun Liu0Xianwu Yang1Department of Gastroenterology, The Shijiazhuang People’s HospitalDepartment of Gastroenterology, The Shijiazhuang People’s HospitalAbstract Background This study aimed to explore the role and underlying molecular mechanisms of long non-coding RNA (lncRNA) LINC00342 in gastric cancer (GC). Methods The expression of LINC00342 in GC tissues was evaluated by Quantitative reverse transcription polymerase chain reaction (qRT-PCR). Silencing of LINC00342 was conducted to investigate the effect of LINC00342 in vitro and in vivo. The underlying molecular mechanisms of LINC00342 were determined by dual luciferase reporter assay, Western blotting analysis and rescue experiments. Biological functions of LINC00342 were evaluated by cell counting kit-8 (CCK-8) assay, colony formation assay, wound healing assay and Transwell assays. In addition, a tumor model was used to verify the effect of LINC00342 in tumorigenesis in vivo. Results LINC00342 was significantly upregulated in GC tissues and cell lines. Silencing of LINC00342 efficiently inhibited proliferation, migration and invasion of AGS cells in vitro, and also suppressed the tumorigenesis of GC in vivo. Functional experiments showed that LINC00342 regulated the expression of canopy fibroblast growth factor signaling regulator 2 (CNPY2) by competitively sponging miR-545-5p. Rescue experiments showed that inhibition of miR-545-5p and overexpression of CNPY2 significantly reversed cell phenotypes caused by silencing of LINC00342. Conclusion LINC00342 plays a potential oncogenic role in GC by targeting the miR545-5p/CNPY2 axis, and might act as a novel therapeutic target for GC.https://doi.org/10.1186/s12885-021-08829-xGastric cancerLINC00342Tumorigenesis
spellingShingle Run Liu
Xianwu Yang
LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis
BMC Cancer
Gastric cancer
LINC00342
Tumorigenesis
title LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis
title_full LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis
title_fullStr LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis
title_full_unstemmed LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis
title_short LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis
title_sort lncrna linc00342 promotes gastric cancer progression by targeting the mir 545 5p cnpy2 axis
topic Gastric cancer
LINC00342
Tumorigenesis
url https://doi.org/10.1186/s12885-021-08829-x
work_keys_str_mv AT runliu lncrnalinc00342promotesgastriccancerprogressionbytargetingthemir5455pcnpy2axis
AT xianwuyang lncrnalinc00342promotesgastriccancerprogressionbytargetingthemir5455pcnpy2axis